These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1153992)

  • 1. [Plasma concentration of phenytoin in epileptics--importance for the clinician].
    Deonna T; de Crousaz G; Magrini G; Bechtel P; Schelling JL
    Schweiz Med Wochenschr; 1975 Jul; 105(30):936-41. PubMed ID: 1153992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
    Rogozea R; Florea-Ciocoiu V; Balaita C; Luca N
    Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Method for diphenylhydantoin and phenobarbital assay by gas chromatography].
    Khodjet el Khil R; Batt AM; Siest G; Tridon P; Weber M
    Pathol Biol (Paris); 1975 May; 23(5):409-16. PubMed ID: 1105335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.
    Borst SI; Lockwood CH
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):309-14. PubMed ID: 1242131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenytoin intoxication and serum level].
    Beier R; Zschiesche M; Cammann R
    Psychiatr Neurol Med Psychol (Leipz); 1978 Jul; 30(7):414-23. PubMed ID: 704704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of anticonvulsant level determination in the treatment of epilepsies].
    Loiseau P; Brachet-Liermain A; Legroux M; Jogeix M
    Nouv Presse Med; 1977 Mar; 6(10):813-7. PubMed ID: 322087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of phenobarbital, mephenytoin and diphenylhydantoin in the surveillance of anticonvulsant treatment].
    Maitrot B; Hue G; Canonne MA; Rocher A; Landriau N
    Ann Biol Clin (Paris); 1976; 34(2):107-12. PubMed ID: 9890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of phenobarbital and phenytoin in epileptic outpatients.
    Driessen O; Höppener R
    Eur Neurol; 1977; 15(3):135-42. PubMed ID: 852469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of epilepsy in the light of determinations of the blood levels of anticonvulsants.
    Majkowski J
    Pol Med J; 1972; 11(1):202-7. PubMed ID: 5040998
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood levels of phenytoin and phenobarbital in epileptics treated with phenydantin and phenytoinum].
    Rosnowska M; Zieliński JJ; Szukalski B
    Neurol Neurochir Pol; 1978; 12(5):569-73. PubMed ID: 724029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of drug therapy in epileptic children.
    Singh LM; Mehta S; Vohra RM; Nain CK
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):251-4. PubMed ID: 3596850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diphenylhydantoin (Dilatin) and phenobarbital blood levels in epileptic children.
    Buchanan RA; Allen RJ
    Neurology; 1971 Aug; 21(8):866-71. PubMed ID: 5106302
    [No Abstract]   [Full Text] [Related]  

  • 15. The necessity of drug level monitoring in anticonvulsant drug therapy.
    Davis HL; Bailey DG; Johnson GE; Wilson TW
    Can J Physiol Pharmacol; 1976 Dec; 54(6):850-8. PubMed ID: 1021220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in serum diphenylhydantoin levels after withdrawal of phenobarbital in epileptics treated with both drugs.
    Arakawa T; Yoshida T; Tanabu M; Karahashi M; Takagi T
    Tohoku J Exp Med; 1974 Feb; 112(2):165-8. PubMed ID: 4836028
    [No Abstract]   [Full Text] [Related]  

  • 17. [Consequeces of the elimination of a combination drug. Transition from combination antisacer: attention].
    de Crousaz G; Schelling JL
    Schweiz Med Wochenschr; 1977 Dec; 107(51):1932-6. PubMed ID: 594737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patients.
    Eadie MJ; Lander CM; Hooper WD; Tyrer JH
    Proc Aust Assoc Neurol; 1976; 13():89-96. PubMed ID: 1029012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluctuations of plasma phenytoin levels on single dose and twice daily dose regimes.
    Vajda FJ; Merory J; Bladin PF
    Proc Aust Assoc Neurol; 1975; 12():61-4. PubMed ID: 1215397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of plasma diphenylhydantoin levels in epileptic patients].
    Lezama-Dávila CM; Olmos-García de Alba G; López-Anaya A; Valarezo-Crespo F
    Bol Med Hosp Infant Mex; 1983 May; 40(5):256-61. PubMed ID: 6871012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.